We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.7B
AUM Growth
+$1.44B
Cap. Flow
+$559M
Cap. Flow %
3.35%
Top 10 Hldgs %
37.06%
Holding
1,009
New
205
Increased
322
Reduced
257
Closed
210

Sector Composition

Rank Sector Weight
1 Financials 32.01%
2 Energy 14.46%
3 Materials 11.36%
4 Industrials 9.65%
5 Technology 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRSK icon
926
Verisk Analytics
VRSK
$23.5B
-41,000
Closed -$3.46M
VRSN icon
927
VeriSign
VRSN
$25.6B
-25,550
Closed -$2.38M
VSEC icon
928
VSE Corp
VSEC
$6.81B
-5,000
Closed -$225K
WOR icon
929
Worthington Enterprises
WOR
$2.78B
-11,760
Closed -$364K
WSBF icon
930
Waterstone Financial
WSBF
$378M
-12,900
Closed -$243K
WSFS icon
931
WSFS Financial
WSFS
$4.15B
-12,900
Closed -$585K
XRX icon
932
Xerox
XRX
$412M
-332,787
Closed -$9.56M
ZION icon
933
Zions Bancorporation
ZION
$10.5B
-31,275
Closed -$1.37M
VSA
934
VisionSys AI
VSA
$10.3M
-40
Closed -$1.81M
ENZ
935
DELISTED
Enzo Biochem, Inc.
ENZ
-20,820
Closed -$230K
ARAV
936
DELISTED
Aravive, Inc. Common Stock
ARAV
-4,998
Closed -$523K
GOL
937
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-150,145
Closed -$682K
MRTX
938
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-15,900
Closed -$58K
GHL
939
DELISTED
Greenhill & Co., Inc.
GHL
-15,375
Closed -$309K
NXGN
940
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-46,000
Closed -$792K
INFI
941
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-625,865
Closed -$983K
ACOR
942
DELISTED
Acorda Therapeutics
ACOR
-279
Closed -$660K
BBBY
943
DELISTED
Bed Bath & Beyond Inc
BBBY
-44,875
Closed -$1.36M
FRC
944
DELISTED
First Republic Bank
FRC
-18,800
Closed -$1.88M
CSII
945
DELISTED
Cardiovascular Systems, Inc.
CSII
-33,287
Closed -$1.07M
PTR
946
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
-18,000
Closed -$1.1M
ACH
947
DELISTED
Alum Corp of China Ltd
ACH
-19,293
Closed -$248K
AUTO
948
DELISTED
AutoWeb, Inc. Common Stock
AUTO
-88,550
Closed -$1.12M
NPTN
949
DELISTED
NEOPHOTONICS CORP
NPTN
-149,100
Closed -$1.15M
CDK
950
DELISTED
CDK Global, Inc.
CDK
-9,000
Closed -$559K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2017 Portfolio in Review

As of Q3 2017, Connor, Clark & Lunn Investment Management (CC&L) held 1,009 positions worth $16.7B, up 9.5% from $15.2B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $559M of net new capital in Q3 2017, opening 205 new positions and adding to 322 existing holdings. Its largest new stake was The Stars Group Inc.: 4,027,485 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 34% a quarter earlier, followed by Energy and Materials.

On the sell side, the largest reduction was Toronto Dominion Bank, an estimated $104M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2017 buy was The Stars Group Inc.: 4,027,485 shares worth $82.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q3 2017, an estimated $73M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2017 reduction was Toronto Dominion Bank, cutting an estimated $104M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited US Bancorp in Q3 2017, selling an estimated $18.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 37% of its $16.7B portfolio in Q3 2017.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 205 new positions and closed 210 in Q3 2017.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 9.5% quarter-over-quarter to $16.7B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2017, filed 14 Nov 2017.